Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Pathology|April 22, 2020
Fundamental control of grade-specific colorectal cancer morphology by Src regulation of ezrin-centrosome engagementLisa Rainey, Ravi K Deevi, Jane McClements, et al.
Cancer Research|December 15, 2010
Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17Sandra Van Schaeybroeck, Joan N Kyula, Audrey Fenton, et al.
Plos One|July 11, 2013
Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq DataDarragh G McArt, Philip D Dunne, Jaine K Blayney, et al.
The Journal of Cell Biology|September 21, 2021
TRAIL signaling promotes entosis in colorectal cancerEmir Bozkurt, Heiko Düssmann, Manuela Salvucci, et al.
Molecular Cancer Therapeutics|May 30, 2006
Chemotherapy-induced epidermal growth factor receptor activation determines response to combined gefitinib/chemotherapy treatment in non-small cell lung cancer cellsSandra Van Schaeybroeck, Joan Kyula, Donal M Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2015
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPLRobbie Carson, Basak Celtikci, Cathy Fenning, et al.
The FEBS Journal|March 4, 2021
Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancerChristopher McCann, Anna Matveeva, Katherine McAllister, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, et al.
Molecular Cancer Therapeutics|June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cellsWendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
Nature Reviews. Clinical Oncology|January 24, 2018
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, et al.
Pageof 5